CN105603101B - 检测8个miRNA表达量的系统在制备诊断或辅助诊断肝细胞癌产品中的应用 - Google Patents
检测8个miRNA表达量的系统在制备诊断或辅助诊断肝细胞癌产品中的应用 Download PDFInfo
- Publication number
- CN105603101B CN105603101B CN201610121180.8A CN201610121180A CN105603101B CN 105603101 B CN105603101 B CN 105603101B CN 201610121180 A CN201610121180 A CN 201610121180A CN 105603101 B CN105603101 B CN 105603101B
- Authority
- CN
- China
- Prior art keywords
- hsa
- mir
- mirna
- expression quantity
- diagnosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
阶段 | 肝细胞癌组 | 健康对照组 | 肝脏良性疾病组 | 其他组织器官良恶性组 |
验证阶段1(训练集) | 112 | 125 | 75 | —— |
验证阶段2(验证集) | 160 | 150 | 80 | 175 |
合计 | 272 | 275 | 155 | 175 |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610121180.8A CN105603101B (zh) | 2016-03-03 | 2016-03-03 | 检测8个miRNA表达量的系统在制备诊断或辅助诊断肝细胞癌产品中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610121180.8A CN105603101B (zh) | 2016-03-03 | 2016-03-03 | 检测8个miRNA表达量的系统在制备诊断或辅助诊断肝细胞癌产品中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105603101A CN105603101A (zh) | 2016-05-25 |
CN105603101B true CN105603101B (zh) | 2018-06-15 |
Family
ID=55983436
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610121180.8A Active CN105603101B (zh) | 2016-03-03 | 2016-03-03 | 检测8个miRNA表达量的系统在制备诊断或辅助诊断肝细胞癌产品中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105603101B (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106048037A (zh) * | 2016-07-06 | 2016-10-26 | 上海市内分泌代谢病研究所 | 一种人循环miR‑122的检测方法 |
CN107622801A (zh) * | 2017-02-20 | 2018-01-23 | 平安科技(深圳)有限公司 | 疾病概率的检测方法和装置 |
CN107818824A (zh) * | 2017-04-10 | 2018-03-20 | 平安科技(深圳)有限公司 | 一种用于健康评估的健康模型构建方法及终端 |
CN108841962B (zh) * | 2018-08-01 | 2021-11-19 | 博奥生物集团有限公司 | 一种非小细胞肺癌检测试剂盒及其应用 |
CN109609634B (zh) * | 2018-12-24 | 2022-02-11 | 朱伟 | 一种与子宫内膜癌辅助诊断相关的循环miRNA标志物及其应用 |
CN111243673B (zh) * | 2019-12-25 | 2021-11-19 | 北京橡鑫生物科技有限公司 | 肿瘤筛查模型、其构建方法和装置 |
CN112063715B (zh) * | 2020-09-07 | 2021-09-14 | 清华大学 | 一种用于肝细胞癌早期筛查的系统 |
CN112553340B (zh) * | 2020-12-30 | 2021-09-24 | 武汉友芝友医疗科技股份有限公司 | ncRNA在诊断肝癌中的应用、肝癌诊断试剂、试剂盒以及诊断系统 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140113978A1 (en) * | 2011-05-01 | 2014-04-24 | University Of Rochester | Multifocal hepatocellular carcinoma microrna expression patterns and uses thereof |
CN102776185B (zh) * | 2011-05-06 | 2013-07-10 | 复旦大学附属中山医院 | 由血浆microRNA组合成的肝癌诊断标志物及一种诊断肝癌的新方法 |
CN102424858A (zh) * | 2011-12-31 | 2012-04-25 | 厦门大学附属中山医院 | 血清miRNA-483-5p的定量检测方法 |
CN104450703A (zh) * | 2014-04-11 | 2015-03-25 | 中国人民解放军军事医学科学院基础医学研究所 | 一种利用miR-146a为标志物的肝癌患者血清检测试剂盒及方法 |
-
2016
- 2016-03-03 CN CN201610121180.8A patent/CN105603101B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN105603101A (zh) | 2016-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105603101B (zh) | 检测8个miRNA表达量的系统在制备诊断或辅助诊断肝细胞癌产品中的应用 | |
KR20170053617A (ko) | 폐암 상태를 평가하는 방법 | |
CN105671181B (zh) | 用于检测肺癌的基因标志物、引物、探针及试剂盒 | |
CN105986031B (zh) | 肿瘤易感62基因及其应用 | |
CN108841962A (zh) | 一种非小细胞肺癌检测试剂盒及其应用 | |
CN108624695B (zh) | 一种与甲状腺乳头状癌辅助诊断相关的循环miRNA标志物及其应用 | |
CN105950753B (zh) | 一种与肺腺癌辅助诊断相关的血浆miRNA标志物及其应用 | |
CN104140967A (zh) | 与结直肠癌肝转移相关的长链非编码rna clmat1及其应用 | |
CN110383070A (zh) | 癌生物标记 | |
CN109609633A (zh) | 一种与乳腺癌辅助诊断相关的血清miRNA标志物及其应用 | |
CN108103198A (zh) | 一种与胰腺癌辅助诊断相关的血浆miRNA标志物及其应用 | |
CN109055557A (zh) | 一种与胰腺癌辅助诊断相关的血清miRNA标志物及其应用 | |
CN109609634A (zh) | 一种与子宫内膜癌辅助诊断相关的循环miRNA标志物及其应用 | |
Hong et al. | Exosomal microRNAs as novel diagnostic biomarkers in breast cancer: A systematic evaluation and meta-analysis | |
CN108950003A (zh) | 一种用于诊断乳腺癌的miRNA标志物及其miRNA的应用 | |
CN107164531A (zh) | 一种肺癌筛查相关的血清LncRNA标志物及其应用 | |
CN108103199A (zh) | 一种与卵巢癌辅助诊断相关的循环miRNA标志物及其应用 | |
CN109536612A (zh) | 一种与鼻咽癌辅助诊断相关的血浆miRNA标志物及其应用 | |
CN109593851A (zh) | 一种与乳腺癌辅助诊断相关的血浆miRNA标志物及其应用 | |
CN108929910A (zh) | 一种与肺腺癌辅助诊断相关的血清miRNA标志物及其应用 | |
AU2021267468A1 (en) | Methods for identifying a medical condition in a human subject | |
CN106636440A (zh) | 血浆microRNAs用于制备筛查诊断男性群体中肺腺癌患者的诊断试剂的用途 | |
CN106367477A (zh) | 一种与结直肠癌辅助诊断相关的血清miRNA标志物及其应用 | |
CN107746886B (zh) | 一种与结直肠癌辅助诊断相关的血浆miRNA标志物及其应用 | |
CN106086178A (zh) | 一种与胃癌辅助诊断相关的血清miRNA标志物及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Guo Hongyan Inventor after: Yang Chunhua Inventor after: Dong Jiahong Inventor after: Zhang Aiqun Inventor after: Sun Yimin Inventor after: Wang Yahui Inventor after: Gao Yun Inventor after: Xing Wanli Inventor after: Cheng Jing Inventor before: Guo Hongyan Inventor before: Yang Chunhua Inventor before: Dong Jiahong Inventor before: Zhang Aiqun Inventor before: Sun Yimin Inventor before: Wang Yahui Inventor before: Xing Wanli Inventor before: Cheng Jing |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20170124 Address after: 400700 Chongqing city Beibei District Road No. 399 building 28 BOE Applicant after: Chongqing Boao Xinjing Medical Technology Co Ltd Applicant after: CAPITALBIO CORPORATION Applicant after: General Hospital of Chinese PLA Applicant after: CAPITALBIO EHEALTH SCIENCE AND TECHNOLOGY (BEIJING) CO., LTD. Address before: 102206 Beijing City, Changping District Life Science Park Road No. 18 Applicant before: CAPITALBIO EHEALTH SCIENCE AND TECHNOLOGY (BEIJING) CO., LTD. Applicant before: CAPITALBIO CORPORATION Applicant before: General Hospital of Chinese PLA |
|
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190715 Address after: 102206 Beijing City, Changping District Life Science Park Road No. 18 Co-patentee after: General Hospital of Chinese PLA Patentee after: CAPITALBIO CORPORATION Address before: 400700 Chongqing city Beibei District Road No. 399 building 28 BOE Co-patentee before: CAPITALBIO CORPORATION Patentee before: Chongqing Boao Xinjing Medical Technology Co Ltd Co-patentee before: General Hospital of Chinese PLA Co-patentee before: CAPITALBIO EHEALTH SCIENCE AND TECHNOLOGY (BEIJING) CO., LTD. |
|
TR01 | Transfer of patent right |